NDC 53877-101-01 - TERUFLEX Blood with Diversion Blood Sampling Arm Anticoagulant CPD with OPTISOL Red Cell Preservative for Collection of 450mL of Blood
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53877-101
- Requested NDC
- 53877-101-01
- Package NDCs from labels
- 53877-101-02, 53877-101-01, 53877-101-06
- Manufacturer
- Terumo Corporation | Terumo Corp. - Fujinomiya Factory
- Effective date
- 2024-10-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Anticoagulant Citrate Phosphate Dextrose CPD - Terumo Corporation | Terumo Corp. - Fujinomiya Factory | Terumo Corporation | Terumo Corp. - Fujinomiya Factory | 2024-10-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53877-101-01 | TERUFLEX Blood with Diversion Blood Sampling Arm Anticoagulant CPD with OPTISOL Red Cell Preservative for Collection of 450mL of Blood | 4 in 1 BLISTER PACK | KIT | 4 | 1 | |
| 53877-101-02 | TERUFLEX Blood with Diversion Blood Sampling Arm Anticoagulant CPD with OPTISOL Red Cell Preservative for Collection of 450mL of Blood | 1 in 1 BAG | KIT | 1 | 1 | |
| 53877-101-06 | TERUFLEX Blood with Diversion Blood Sampling Arm Anticoagulant CPD with OPTISOL Red Cell Preservative for Collection of 450mL of Blood | 6 in 1 CASE | KIT | 6 | 1 | |
| 53877-111-63 | TERUFLEX Blood with Diversion Blood Sampling Arm Anticoagulant CPD with OPTISOL Red Cell Preservative for Collection of 450mL of Blood | 63 mL in 1 BAG | SOLUTION | 63 mL | 25.5 g in 1000mL | 1 |
| 53877-121-10 | TERUFLEX Blood with Diversion Blood Sampling Arm Anticoagulant CPD with OPTISOL Red Cell Preservative for Collection of 450mL of Blood | 100 mL in 1 BAG | SOLUTION | 100 mL | 900 mg in 100mL | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53877-101 | TERUFLEX BLOOD WITH DIVERSION BLOOD SAMPLING ARM ANTICOAGULANT CPD WITH OPTISOL RED CELL PRESERVATIVE FOR COLLECTION OF 450ML OF BLOOD (DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, ANHYDROUS CITRIC ACID, SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM, SODIUM CHLORIDE, MANNITOL, AND ADENINE) KIT [TERUMO CORPORATION] | 1 | Current NDC, 5 package rows | 20241020_24057196-619a-4218-8e30-35388daee92f.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Worafy Gentle Eye Wash | SODIUM CHLORIDE | Shenzhen Shandian Jingling Technology Co., Ltd. | 4da864dc-e10c-1db9-e063-6394a90a0984 | 2026-03-22 | Warnings | 451W47IQ8X |
| SODIUM CHLORIDE HYPERTONICITY | SODIUM CHLORIDE | YYBA CORP | 439653b9-99b8-4799-8d67-4a2ada9c6783 | 2026-03-20 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Altachlore Sodium Chloride Hypertonicity Ophthalmic 5 Percent | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | e13fd053-9420-490c-a43e-e14b0930cb4e | 2026-03-18 | Warnings | 451W47IQ8X |
| Universaltox | ALFALFA, AVENA SATIVA, FUCUS VESICULOSUS, HORDEUM VULGARE, NASTURTIUM AQUATICUM, RAPHANUS SATIVUS, TRITICUM AESTIVUM, IODIUM, UBIDECARENONUM, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, MANGANESE GLUCONATE, ORYZA SATIVA, THYROIDINUM (SUIS), CALCAREA CARBONICA, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), RHUS TOX, CORTISONE ACETICUM | BioActive Nutritional, Inc. | ad454e8a-4f78-4aac-90d9-a3f26a6fbe42 | 2026-03-17 | Warnings | 451W47IQ8X |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | LX22YL083G |
| TINTED SUNSCREEN FOUNDATION | TINTED SUNSCREEN FOUNDATION | Guanghzou AiXin Biotech Co Ltd | 396393c4-b50c-3877-e063-6294a90a0e9b | 2026-03-17 | Warnings | 059QF0KO0R |
| BM BIO27 | CALC PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d229815-05f4-27c5-e063-6394a90ac865 | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO1 | CALC PHOS, FERR PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d265d99-fdbb-5efb-e063-6394a90a89ac | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO16 | CALC PHOS, FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d26b4a9-ee27-6915-e063-6294a90a5d4d | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO12 | FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d2747ad-958e-63a1-e063-6294a90aea66 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b812c9-fb0a-5ee0-e063-6294a90a03e1 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b88e7c-eca0-5540-e063-6294a90a1b18 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b8c3f4-e528-c69d-e063-6294a90a5a34 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b7eb13-39c3-6f0e-e063-6394a90a4011 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b8bb9c-d30f-152f-e063-6394a90a5208 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b8dcbd-9e6b-1edc-e063-6394a90aac73 | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO20 | CALC FLUOR, CALC SULF, KALI SULF, NAT MUR, NAT SULF | BM Private Limited | 4d285396-9df8-86bc-e063-6294a90ad4de | 2026-03-16 | Warnings | 451W47IQ8X |
| DEXTROSE | DEXTROSE | HF Acquisition Co. LLC. DBA HealthFirst | 4d2d3d3d-d96e-4005-e063-6394a90afd9a | 2026-03-16 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.